ADMA BIOLOGICS, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $510.2 | $426.5 | $258.2 | $154.1 | $80.9 |
| Operating income | $191.4 | $139.0 | $21.6 | -$39.4 | -$58.4 |
| Net income | $146.9 | $197.7 | -$28.2 | -$65.9 | -$71.6 |
| Cash Flow Statement | |||||
| Free cash flow | $27.8 | $110.4 | $4.0 | -$73.4 | -$125.9 |
| Share repurchases | $31.9 | $0.0 | $0.0 | — | — |
Shares outstanding 224.0M · Free float 91.0%
Annual filing data through FY ended December 31, 2025; float as of October 11, 2026.